VestGen Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$860K Sell
10,078
-2,151
-18% -$195K 0.03% 452
2026
Q2
$1.12M Buy
12,229
+573
+5% +$50.1K 0.03% 432
2026
Q1
$1.02M Buy
11,656
+2,098
+22% +$187K 0.03% 456
2025
Q4
$755K Buy
9,558
+3,185
+50% +$250K 0.03% 400
2025
Q3
$509K Buy
6,373
+1,150
+22% +$98.1K 0.02% 480
2025
Q2
$475K Buy
5,223
+954
+22% +$87.1K 0.02% 431
2025
Q1
$400K Buy
+4,269
New +$382K 0.02% 418

Other funds holding CL

VestGen Advisors's CL Position: Q3 2026 in Review

VestGen Advisors reduced its Colgate-Palmolive (CL) stake by 18% in Q3 2026, selling an estimated $195K and leaving 10,078 shares worth $860K. The position accounts for 0.03% of the portfolio, ranked #452.

VestGen Advisors first reported a position in CL in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.12M in Q2 2026. 1,142 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • VestGen Advisors held 10,078 shares of Colgate-Palmolive worth $860K as of Q3 2026.
  • VestGen Advisors sold 2,151 Colgate-Palmolive shares in Q3 2026, an estimated $195K.
  • Colgate-Palmolive made up 0.03% of VestGen Advisors's portfolio in Q3 2026, its #452 holding.
  • VestGen Advisors first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 7 quarters since.
  • VestGen Advisors's Colgate-Palmolive position peaked at $1.12M in Q2 2026.
  • 1,142 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.